“Discovery and predicted consequences of non-coding sequence variants affecting gene expression on a genome-scale and in inherited breast cancer.”
The IFOM-IEO Campus is a new biomedical research centre, created by the joint efforts of the FIRC Institute of Molecular Oncology Foundation (IFOM) and the Department of Experimental Oncology of the European Institute of Oncology (IEO), which have expanded and integrated their research activities on a common campus.
The IFOM-IEO Campus is located in Milan, the heart of the commercial/industrial north of Italy, where it benefits from numerous interactions with other scientific and medical organizations in the area (see participants below). The Campus is also home to the Ph.D programs of the European School of Molecular Medicine (SEMM), which it is running in collaboration with the University of Milan, the University of Naples “Federico II” and the Italian Institute of Technology (IIT) in Genoa.
Host: Dr. Paolo Peterlongo
Fondazione IRCCS Istituto Nazionale dei Tumori, May 15, 2013. 02:00 PM
“Discovery and predicting impact of non-coding sequence variants that affect gene expression on a genome scale and in inherited breast cancer”
Since its founding of the objectives of the Istituto Nazionale dei Tumori via Venezian were defined as follows:
- Research in the field of cancer to better understand the biological mechanisms and systems to continuously improve diagnosis and treatment.
- The diagnosis and treatment of cancer, with the methods that are recognized internationally as the most valid.
- The oncology information of citizens and the training of medical and nursing staff involved in the treatment of cancer.
Host: Dr. Paolo Radice – S.C. Medicina Predittiva: basi molecolari del rischio genetico e TestGenetici, Dipartimento di Medicina Predittiva e per la Prevenzione.